The IDMP data standards provide structured medicinal, pharmaceutical product and substance data models, as well as mechanisms to uniquely identify products and their components. As well as facilitating a wide range of exciting regulatory and healthcare use cases, the standards can help organizations overcome traditional information silos and inconsistent data quality across different functional areas, […]
Read moreExploring IDMP use cases: don’t sell your organization short
Published onThe suite of ISO IDMP data standards has the potential to support a broad spectrum of transformational new healthcare and regulatory applications. Yet articulating the benefits of IDMP adoption to a CEO or CIO remains a challenge for project proposers, who must confront the common perception that this is merely another compliance cost. Iperion Life […]
Read moreWebinar IDMP Implementation Guide with Main 5
Published onOur webinar on EU Implementation Guide on 30 March 2020 was a success. We have noticed there is a clear need for practical information on the Implementation Guide and the necessary next steps. Due to this success we are planning new webinars on the Implementation Guide, together with MAIN5, especially for the DACH-region. EU ISO […]
Read moreWebinar EU Implementation Guide
Published onIn February 2020, EMA published Iteration 1 of the EU ISO IDMP Implementation Guide. The EU IG provides detailed guidance on how ISO IDMP data fields should be interpreted, submitted and maintained within the EU regulatory framework supported by SPOR (Substances, Products, Organisations and Referentials Management Services). Webinar In order to assist with the digestion […]
Read moreArticle | Capitalizing on Standardized International Product Data
Published onThe latest regulations for human and veterinary medicinal products, as well as medical devices, include the mandate to set up databases with detailed information about available products. These databases must be realized and implemented in the near future, and require a concerted effort now if tangible real-world benefits are to follow. An article of Associate […]
Read morePutting the EMA medicines database to effective use
Published onGoals for IDMP in Europe must not be diluted in 2020, if standardized medicinal product data is to be of tangible real-world benefit, says Iperion’s Remco Munnik in PharmExec.com. An eye-watering level of investment has been ploughed into the preparations for the EU’s implementation of the ISO IDMP (identification of medicinal products) standards over recent […]
Read moreArticle | IDMP: Making patients the priority in 2020
Published onIDMP is at a crossroads. In 2020, will veterinary regulations disrupt progress on human medicinal product standards, and in the meantime who’s speaking up for patients? Iperion calls for focus and mutual support during what will be a critical year for the regulatory network’s product transparency initiatives. An article of Managing Director Frits Stulp is […]
Read morePartnership with Gens & Associates
Published onIperion Named Strategic IDMP Advisory Partner in New Gens & Associates Program Offering Complete Regulatory Information Management Support to the Life Sciences Industry European life sciences consultancy Iperion is one of just two strategic consulting partners globally to have been invited to join a new premier Regulatory Information Management membership program devised by Gens & […]
Read more